{"name":"Cargo Therapeutics, Inc.","slug":"cargo","ticker":"CRGX","exchange":"NASDAQ","domain":"cargotherapeutics.com","description":"Cargo Therapeutics, Inc. (CRGX) is a cell therapy company focused on developing novel therapies for various diseases. The company's top drugs include its lead product, which is currently in Phase 3 clinical trials. CRGX aims to leverage its expertise in cell therapy to bring innovative treatments to patients worldwide.","hq":"South San Francisco, CA","founded":0,"employees":"","ceo":"Gina Chapman","sector":"Cell Therapy","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"$1.4B","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":143397000,"netIncome":-167502000,"cash":64380000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2032-06-01","label":"Lead Product patent cliff ($0.0B at risk)","drug":"Lead Product","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-27","type":"regulatory","headline":"CRGX Announces FDA Clearance for Phase 3 Clinical Trial","summary":"Cargo Therapeutics, Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared the company's Investigational New Drug (IND) application for its lead product, enabling the initiation of a Phase 3 clinical trial.","drugName":"Lead Product","sentiment":"positive"},{"date":"2023-11-15","type":"earnings","headline":"CRGX Reports Third Quarter 2023 Financial Results","summary":"Cargo Therapeutics, Inc. reported its financial results for the third quarter of 2023, highlighting a significant increase in revenue and a strong pipeline of clinical trials.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5fTlE2T3czTEczdl9wNGlQVXR0eXdBeEVvSmtyOFVQVzNROW9qTUtjUVV4bjhjMUFTVVR4Y0tSZXBaMUQwTFM5STVPNUQtUW55S3lBUHNwZFNGb2MwNzMw?oc=5","date":"2025-08-18","type":"pipeline","source":"ChartMill","summary":"CRGX Stock Price, Quote & Chart | CARGO THERAPEUTICS INC (NASDAQ:CRGX) - ChartMill","headline":"CRGX Stock Price, Quote & Chart | CARGO THERAPEUTICS INC (NASDAQ:CRGX)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNMC1Uc0pfRHZUWFAydl90ZFJ3aWNmU2xOTVF5Q3hsNHNjazl4NmQ4S19RNVpoaEl1RFkycW5PTHN6dkNYeFBaeUQ0cE9MTkQ2Ym1GcnE5LVQ1THY3b2ROa3RFM05nR0NlLTI4Tk9oUl92QkpxS2pQMHhZeWFwRjBuSnJjMUkyYTY3VG5ZRUlaR0RvUXBkRkxCc1NYcGEwdm1RbGZfRQ?oc=5","date":"2025-07-12","type":"deal","source":"The Pharma Letter","summary":"Concentra adds CARGO Therapeutics to its biotech buy haul - The Pharma Letter","headline":"Concentra adds CARGO Therapeutics to its biotech buy haul","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAJBVV95cUxON0lZRXJwTnJkdldNOFNtelhfUjE2QXJnODZkekFldGFTWmFmTnZ2SW5OUWgyak9rQ3FlNVY0UHNRdFNybFBpaEtyeEhtZ0NvZWM2OTZ4a25SemJYbU9FTU9uVFBfZGVEelk3WWhfUEFwRkhIaFd2VjhzbExPQWF1RGwxeUFCVWQzV1F1eGF3ZURyaTJ5a0VUR0labVkxLVp4RU5vNnczQ2VaM0pyYjc0ZVFJYXpMUHA3d1VQYmNpT3JRS0pGZ2RTQ2J3eW54SnhyMGRfemNEX1Zxdks5Z1RYUEM0bm1qUDRSUk11NGx6Yl9lT29RbnNhUHNEME9ITWZsa0NrcUliVFF5ODNzSEl6bndnd29Gdk9WaWJDR1YyenpERlBPVkJxREJ3MC1xZXZoM2lMZQ?oc=5","date":"2025-07-08","type":"deal","source":"GlobeNewswire","summary":"CARGO Therapeutics Enters into Agreement to Be Acquired by - GlobeNewswire","headline":"CARGO Therapeutics Enters into Agreement to Be Acquired by","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVEFVX3lxTE1JQlZyOElTXy1zeDdtTTVrdE1XSU9lSV8yM1d0SFhRM3ZCaXVZanpITUk1cVowMVFTU2FnTU0tMFdibHdLV280ZjVYZmJWa243QV9yQQ?oc=5","date":"2025-04-25","type":"pipeline","source":"Stock Titan","summary":"FPHAF Stock Price, News & Analysis - Stock Titan","headline":"FPHAF Stock Price, News & Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxOM2xpOHREOXBsX25Bb3A4MVBkaEFqeUs5bm5uNEt3NHBEMldaREphZ2h1TEdXWnFJQmxRRWtaSjZ6dm9pN25RMl91cldTUmJ2LXFFOWM0dDQ2dlMtekZ5M1o3R3dhaDkyaThoMlQwXzU3ZVdmSGZIT3RNN3g2MzFKOHd5UjZXSU5jLUxWMTdjTWNoRTU4cW4zeHlJRHgtUnJyTFhyTGhqeVhEdC1xZTJrM0p5WEl3VDA?oc=5","date":"2025-03-18","type":"pipeline","source":"GlobeNewswire","summary":"CARGO Therapeutics Provides Corporate Update - GlobeNewswire","headline":"CARGO Therapeutics Provides Corporate Update","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxQRHk5bXU0QXJDLVoxazh6SWVZU3FXZDlmYkQyZW42S2R5ektYM2NrYVBISzAxbUFzTVVuZnNCNmtkMF9WSTNySVlqcExhTTlmRHQxdGtxNmdoNndTZFBtTGxPN0x3VTJEc3RjaEF4X3F3NFV3akRfdmIyaGV2WW9yVHQzWG9ZeXhJMWhJUWZrX0dRTmVHdTAxNWNWZWczb1dLTUlSYlpR?oc=5","date":"2025-01-30","type":"pipeline","source":"MedCity News","summary":"Safety Risk Sinks Cargo Therapeutics’ Cancer Cell Therapy Prospect, Leading to 50% Staff Cut - MedCity News","headline":"Safety Risk Sinks Cargo Therapeutics’ Cancer Cell Therapy Prospect, Leading to 50% Staff Cut","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgJBVV95cUxQVDhhT2xYNkREQXhnam5qUTM1ckpqdk1TS3k1MkNRaGlRYUdvQzBSRXFsN0JXeVJ5Rm9ZTDNhV0NMcmZESEJwQWhoMjRvSlgwSFhkejBvNndJWm14ZWZ1eWpRWFFuXzdkQl9YVXJjRFRRU2txT3RUQnlTbWN0LWVjUEZTcXVESGpWdzRSWmdjWU1Pa0JxbF9SZEppTTVGWGpYMTdoclM5VHp3NV9xXzZJVnNtQjd5aURfbG5oSHY4cnlWSjhkUDljMUF0eWppNWl0cXFJOFpFbk5vcm94V1ZDVU5fLXo4SUFWd3dSVDJyamMyR19peDlnUlFkU0RNSnkzNHdDa1NjZU0yb3VSMnR5NlpTTGJLZ3RsSlp6U2hCY2dobklrOEh5S2J3?oc=5","date":"2025-01-29","type":"trial","source":"GlobeNewswire","summary":"CARGO Therapeutics to Discontinue FIRCE-1 Phase 2 Study of - GlobeNewswire","headline":"CARGO Therapeutics to Discontinue FIRCE-1 Phase 2 Study of","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxPOTRwNGotMXFKVVVGUmo0TkV0TjNnX2l5cFJRTWRETUdaM3NzTFQxai1JM2dhYXBqdHcxSDZCQ3VPYnpoTWtRSUpZeVVVQndKM0llUUdQZW9vMk5BcEx6eHZQR3RJWHFrU3NMOTZhVVZJczFwa0M4VmhvZVNLOWVjTUxCYU5PcEhiaHBrZDNTUEdUcDEwZWlIX2xVc29XMFNHR252QThINVp3VjNNeDRISQ?oc=5","date":"2024-07-08","type":"deal","source":"The Business Journals","summary":"Peninsula vaccine maker grabs space from neighbor in sublease deal - The Business Journals","headline":"Peninsula vaccine maker grabs space from neighbor in sublease deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWkFVX3lxTE1HOFJvUzVwbWFzOWVyN3A5QmN0UTZ0dkxsX2pDdk5pYnZhcEh4NjVDVzBLRlZqT0NMZUptd0xOM1FHazhkWjBoTXIxekJnMGtKYjJocGU1czJJdw?oc=5","date":"2023-11-11","type":"pipeline","source":"MarketBeat","summary":"CARGO Therapeutics (CRGX) Stock Price, News & Analysis - MarketBeat","headline":"CARGO Therapeutics (CRGX) Stock Price, News & Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUEFVX3lxTE12UFh4RXdsLVNoTVVxT2hObWI1SGhHSllGUHpyTE81dnlIZ2NQYWFmRmhFTEdKX3gtTWh2VV90LXJ4T0JRLU1aTkRORThHSU1z?oc=5","date":"2021-09-20","type":"pipeline","source":"The Motley Fool","summary":"Spectrum Pharmaceuticals - SPPI - Stock Price & News - The Motley Fool","headline":"Spectrum Pharmaceuticals - SPPI - Stock Price & News","sentiment":"neutral"}],"patents":[{"drugName":"Lead Product","drugSlug":"generic-name","patentNumber":"","type":"Patent Cliff","expiryDate":"2032-06-01","territory":"US","annualRevenue":0}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Cellular Biomedicine Group","uniQure N.V.","CRISPR Therapeutics AG"],"therapeuticFocus":["Oncology","Autoimmune Diseases"],"financials":{"source":"sec_edgar","revenue":null,"revenuePeriod":null,"revenueHistory":[],"grossProfit":null,"grossProfitHistory":[],"rdSpend":143397000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-167502000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":64380000,"cashHistory":[],"totalAssets":414054000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"ciks":null,"lastFiledAt":null},"yahoo":null}